

Jan 12 (Reuters) - The chief executive of rare disease drugmaker Shire Plc on Tuesday suggested that the company could achieve much higher cost saving...


(ShareCast News) - The FTSE 100 continued to recover some of its losses from the start of the year, rising 107.03 points (1.82%) to 5,978.86 by mid-af...


(ShareCast News) - Shire got a boost on Tuesday after Credit Suisse upped the stock to 'outperform' from 'neutral', following the proposed merger with...


(ShareCast News) - Shire's $32bn takeover of Baxalta caps the company's transformation from a specialist in pills for teenagers with attention deficit...


* Enlarged group to be world leader in rare diseases * Deal offers $18 and 0.1482 Shire ADS per Baxalta share * Baxalta haemophilia business a potenti...